-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 BWeqqapRPlPlKqa5/fUa1G1R8LmB8FOWRk6bXlJK92Z2s56aR1KQyxVo5Bgn3oN1
 8dRAYUW+WK2FMV6RWhlClg==

<SEC-DOCUMENT>0000950123-07-009223.txt : 20070626
<SEC-HEADER>0000950123-07-009223.hdr.sgml : 20070626
<ACCEPTANCE-DATETIME>20070626103522
ACCESSION NUMBER:		0000950123-07-009223
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20070625
ITEM INFORMATION:		Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20070626
DATE AS OF CHANGE:		20070626

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MILESTONE SCIENTIFIC INC/NJ
		CENTRAL INDEX KEY:			0000855683
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				133545623
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14053
		FILM NUMBER:		07940247

	BUSINESS ADDRESS:	
		STREET 1:		220 S ORANGE AVE
		STREET 2:		LIVINGSTON CORPORATE PARK
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039
		BUSINESS PHONE:		2013793171

	MAIL ADDRESS:	
		STREET 1:		44 KEAN ROAD
		STREET 2:		220 SOUTH ORANGE AVE
		CITY:			LIVINGSTON
		STATE:			NJ
		ZIP:			07039

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	U S OPPORTUNITY SEARCH INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>y36470e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>






<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Date of Report (Date of earliest event reported) </B><U><B>June&nbsp;25, 2007</B></U>
</DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>MILESTONE SCIENTIFIC INC.</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 1pt; width: 75%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt"><B>(Exact name of Registrant as specified in its charter)</B></DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>0-26284</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>13-3545623</B></TD>
</TR>
<TR style="font-size: 1px">
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>(State or other jurisdiction</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(Commission</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>(IRS Employer</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>of incorporation)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>File Number)</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>Identification No.)</B></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>220 South Orange Avenue, Livingston Corporate Park, Livingston, New Jersey 07034</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 1pt; width: 75%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt"><B>(Address of principal executive office) (Zip Code)</B></DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Registrant&#146;s telephone number, including area code </B><U><B>(973)&nbsp;535-2717</B></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>N/A</B>
</DIV>

<DIV align="center"><DIV style="font-size: 3pt; margin-top: 1pt; width: 75%; border-top: 1px solid #000000">&nbsp;</DIV></DIV>

<DIV align="center" style="font-size: 10pt"><B>(Former name or former address, if changed since last report)</B></DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy
the filing obligation of the registrant under any of the following provisions:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="3%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">









<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;5.02:</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;See our response to Item&nbsp;8.01 herein.
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;8.01:</B></TD>
    <TD>&nbsp;</TD>
    <TD><B>Other Matters.</B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June&nbsp;25, 2007, we issued a press release, a copy of which is attached hereto as Exhibit
99.1 and is incorporated herein by reference, announcing that David Cohn, our current Chief
Financial Officer, has indicated his intent to resign from the senior financial post to pursue new
career opportunities and consequently, we have initiated a search for a new CFO. Mr.&nbsp;Cohn has
agreed to continue serving us until his replacement is hired and will offer his ongoing support
through a reasonable transitional period.
</DIV>

<DIV align="left" style="margin-top: 12pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; background: transparent; color: #000000">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD></TD>
</TR>
<TR valign="top">
    <TD nowrap align="left"><B>Item&nbsp;9.01:</B></TD>
    <TD>&nbsp;</TD>
    <TD><B><U>Financial Statements and Exhibits</U></B></TD>
</TR>
</TABLE>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;Exhibits:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;99.1 Press Release dated June&nbsp;25, 2007.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>MILESTONE SCIENTIFIC INC.</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Leonard Osser
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Leonard Osser<br>Chairman and Chief Executive Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Dated: June&nbsp;25, 2007
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>y36470exv99w1.htm
<DESCRIPTION>EX-99.1: PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><IMG src="y36470y3647000.gif" alt="(MILESTONE LOGO)">
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>MILESTONE SCIENTIFIC ANNOUNCES PLANS<BR>
TO APPOINT NEW CHIEF FINANCIAL OFFICER</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B><I>Current CFO to Resign to Pursue New Career Opportunities</I></B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B><I>LIVINGSTON, N.J. &#151; (PR NEWSWIRE) &#151; June&nbsp;25, 2007 </I></B>&#151; Milestone Scientific, Inc. (OTCBB:MLSS),
the recognized leader in advanced injection technologies, today announced that David Cohn, current
Chief Financial Officer of the Company, has indicated his intent to resign from the senior
financial post to pursue new career opportunities. Consequently, the Company has initiated a
search for a new CFO that it expects to appoint as soon as possible. Cohn has agreed to continue
serving Milestone until his replacement is hired and will offer his ongoing support through a
reasonable transitional period.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Leonard Osser, Chairman and Chief Executive Officer of Milestone, noted, &#147;We would like to thank
Dave for his exceptional leadership over the past year and wish him well in his future endeavors.
Milestone has already initiated its search for Dave&#146;s replacement.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B>About Milestone Scientific, Inc.</B><BR>
Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary,
highly innovative technological solutions for the medical and dental markets. Central to the
Company&#146;s IP platform and product development strategy is its patented <I>CompuFlo</I><SUP style="font-size: 85%; vertical-align: text-top">&#153;</SUP>
technology for the improved and painless delivery of local anesthetic. Specifically, <I>CompuFlo </I>is a
computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology,
which provides real-time readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids. The <I>Single Tooth Anesthesia</I>
(<I>STA</I><SUP style="font-size: 85%; vertical-align: text-top">&#153;</SUP>) computer-controlled local anesthesia delivery system which uses this technology
provides dentists with audible and visual signals as to in-tissue pressure. Milestone&#146;s existing
painless injection systems are currently sold in 25 countries. For more information on these and
other innovative Milestone products, please visit the Company&#146;s web site found at <U>www.milesci.com</U>.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><B><I>Safe Harbor Statement</I></B><BR>
<I>This press release contains forward-looking statements regarding the timing and financial impact of
the Milestone&#146;s ability to implement its business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are based on assumptions involving
judgments with respect to future economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict accurately and many of which are
beyond Milestone&#146;s control. Some of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements are general economic conditions,
failure to achieve expected revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes in customer and market
requirements and standards, and the risk factors detailed from time to time in Milestone&#146;s periodic
filings with the Securities and Exchange Commission, including without limitation, Milestone&#146;s
Annual Report on </I><I>Form 10-KSB</I><I> for the year ended December&nbsp;31, 2006. The forward looking-statements
in this press release are based upon management&#146;s reasonable belief as of the date hereof.
Milestone undertakes no obligation to revise or update publicly any forward-looking statements for
any reason.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FOR MORE INFORMATION, PLEASE CONTACT:<BR>
Elite Financial Communications Group, LLC<BR>
Dodi Handy, President and CEO, or<BR>
Daniel Conway, Chief Strategist<BR>
407-585-1080 or via email at mlss@efcg.net</B>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio -->
</DIV>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>y36470y3647000.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 y36470y3647000.gif
M1TE&.#EA[``Y`.8``(=S=//TZ^C3T^<I7OK[\MO6R79M=JJPSL.[M7!GC:>9
MCLK$NO3R\J^DF%-&5/W^]Y*+JA002_/IZDY%;MW8TS<O1PX+-<:[PX%X@Z62
ML-7+R$<\2])@C6)7<O[^_K:LILO$QK8E3NWLXKRTIYF*A/KY^)*#>OCV\>/A
MVEL3*MM$=+RTM^WLZ?[^^_S\^ZJAI*YKC)JDR.?=WNKHWO#PYSHR9=#(O^/C
MTRLD/.KFY)*8P>GEW/WX^IV4EI2+D?7O[]?3WAD47]7,TUY27H!YH(2-M?KV
M^(V`A;:KMXF"F?[[_"4>4M?1P?WZ^\;%V-*>L=_=T?O\^.?BX)VFJH8=/O;X
M[>'@RJ"2AL;!LO'BZ*I^I.^+HJ^FMZF;P/W]_?S\_?K\^PX+(?_\_>CJW>OC
MU[Z\J1P7+\&$H_KY^^KLTO?XXB,<9OW]^_#GXNWK[N?MX/;U]=/3R&UB:NNW
MQ.?CZ+"ZU;>SF:Y-;]#/N\G)M/CX]9:5I-[;W_'P[N;FV?___R'Y!```````
M+`````#L`#D```?_@`\M7UY1!`11B6AH7H)_CY"1DG]>+2U>:'J&B"XN40]1
M7I.CI*6FIZBIJJN2'AY_KJY>8&`N2IVT+EYB8EY>KZS!PI%18'TK&$00$$E$
M"4D7+"[`J98E='L)RD7.&"`/)4K#X^3EYI`>O]3ILRX\32Y@K^E?8A[VY_FC
M:%$S$#@1U@@<F,`)HU7@W'"I,7!)D"4=+I3HI:^BQ8KI8/V"%<O+EX]?8GT!
MHX[:Q7-?C$#Y8*!"A"`P8=:`D$.4*C$_A"2(&<&,`PP*F/PX2;3HN%B/+/WY
M^"M4DR9*//HR:718"R,R;#1H^3)FD`X@HE`M]0#%0IX5CMA9((/!EZIP_^-*
M4OK(51,&;F3(R-&G2A0730BE<R77:I0?%!`TD%/!Z\,]TL:.4K,@@4.8$88T
MP$+AAY('#PJ++JK4"QP^(%9PF;*G1P\%9YYH:,-#EX>HHUEY2`1'B@T%'2['
M3`!$C^1):3+4\+H$@XTQ`<2R:9&[ND4X0)#XP)"D&0SN&.Z$N,/AB022^*RG
MBJ5G!A8#PF5R$5&"A[@_E^YQ]`!'0(<US/D`!2(>6-)",2X8P8,8TUD2!1O`
M\'*)%P3,,LH]L138`F@/-"&()2Y`F$XH7[CPAQC[/5*)6!X\0("!KK3@P710
ME3:CC`4B)88ELHBAA`?RM%,%$V?`((<!`-P!0_\2=]RA!03BC0<#%T`$H$04
MC]13B(R7\-`B.QEJE`Y)4YVH(6$DL7B/$E]$404M)Z+82@!,)+&<5VLD0$$X
MENR(HQ(.LG#!G3$MX<,;G]SHQ2T$U%<;&_"H<Z*,#Q#R0('H$";++UZX<$D+
M3[$!QH-_1>6"(%=JZLI;7GC81"4/*-$$CK*X4&(4+3#(HP<AN7+IF;Z(04@G
MG98@``PA)#N>DAG`X&0&=PQPQQD0%,%%'-$=V.J6+1+01(NTTJ.1)4^=*J,8
M-7*XZ#0E5`(J#P^R@:N<DNA1``2$QE3#"C0L"$MZ7U@2``I$`!C@&R4,\NI3
MA1"@AAY>L&$;)(7H08#_'D80<&()@VGZ"QO3(=@$#Q9[LHFPIRI1VRL!"^(%
M#P_HX88;##RU(2BQ)+))%#R<0,`#"BHA]`-J7$Q`%6]>2LLM'C"@`0?*AJ`"
M!UIHT475.D"@@@IG'*!#$7M,L4`68!AG1*=&H%%"%7"$E.@\'A$B+P$\9+PV
M`;JX</0A/?OXB8OO^.4)=9G^00`%^#H6Q!I$4$``/C'&2(`(@RJ^Q!%C>(1&
M%2]T,($V1#23P.<@G."%&QAT`'HS1'BN`,3KB**$#!FH3L3MH3N30`*J:[,[
M$A+``H:++?#`1Q(3U*!\`ESP00<((*`QDA$@)`$Z[MUUIXSVN#OS0A0C^5+%
M_QQW4)'L`"IH$8,6',!0K0XZ:-%U'3'HT,41=SR!M!<Z=8"[-A<X4ZW0\`$Y
M^$][O$-"'^#0N=T1(1G*T%T';+<[".B!#9$@S`D*X(/E1*`K\J%!NQXA!@*X
M@@UJH``&UF`!QZP!`S0@%@U6T)(P+`Y`$6A.E:H@!2+@(`P!P6$$.E`&!N@!
M%E]`0T:PDH$*6*"%`@G"$Z<8AC"T<(@40")HT."$&E@`!T,8@A,C4(,)K*$#
M?.#!Y!(7@2D^<7%P=*,%NM(!..!"#U"(TM;0QX$,<&```X!!$>`7@_H=H'[(
M:A(3:$`#(<CAC0`Z(Q_TP`/JN,(%#,""''`P1P!98/\"%Z"#")#@Q1;&Y(E6
MM$`J7U(#%!AA%/;JH!1-"9,E$`$*'-/(KW@0@`M,8(X@7!P&QC"-+_0A#BNX
M@@.ZDL,CE*$`(J#!#<J@@$>>T@%VL$$?C#,-I.B!#`MXP1```I,O#@$#1\``
M`,8YQPF`H`1N8P`7?KD!$V2@!U>0PQ),.0$AG"``5BC8$RM`T`J0$S,X*&@%
MS-#"&LS@!/$000/.M[6M<8`#*@#D'2``OR+4KWXZ2"0`CD"!-T`!`0`XJ#!1
M0`!Y">^8(_"!`X#I@!<(0`!DT`H&.(D9"YQSI"80XQR7$(?@32*6-6CC'+T"
MRBK410P/F`8#"+:&,%0@/LW_&4/"/%`%"ER@`0`0CJ$6@`(XP`$%<?C`%1J#
M&3F4`0H,F(8HD%*"',1A!"08PF4BX``3**`!#5``"0#@DAHL(`#R8``0.M!&
M$C3@`TAHP!5:TM`1J"$'-C#`0X8```"8``!R(%0$Y.#9D3*&C'B@P5T6H$<.
M;.&U&.4C1W60`4)>#0)3@`'^J'"&-,0!"UL)YA+V,`,]'$@L#*#``CYPA*2.
M=@4"D$`6!("`:CH$0)?[:V`'NX&`E.$'-HG$!NT4!#.H5"`^\,,T3N0B#V0!
M!!/HB5Z98P`_&/</#Z`!=4E`J`HH0`/2^$)O%M``,P;A@P980`ZZ><F,F&8&
M3-C*_YTRTX,RY,$&6!A!-2-0`00$(&!2>`$.[5`&/`C!!AJ6`RL;D`8Z7*`#
M%NBK`NSP@0:88,(1,,%C:SS9#]I!`GT@`PS,-P#7WG0.6[@HM099R$)VH0M%
MPF@(J$"%.V@`!108P5KA"),)$+=!?R@!"ZP`W."8`0!X&$,53I`%#=B!OSC$
M00]&L``0Y,$."@AK!,K0!A-)H@0%L%,$<.``'#BF!@BHPD;^4`4C:,`'4I2#
M/O%D@!LDC'!Z0,$'&"*3#\R@!'5Q`0OPT`&>8,`*<#B%%QA@@^9B9@@C\$,?
M&"""&]B@!S@`I1H\8`0\[.0A%Y"!!(Z&`BPH8)DU>,$-Z/_0A1J8P9D%V($4
MF/`"`Q^X`4R8@1\*$,X-F&$%;6@#`I3EVCED8;I(%H(3O!:#0Q[@D'4X`R`'
MD"PJG^$&+"C`$TK]1IDD000GX(&%T)"%S"[!4'Y(F!A<`(<"%+A0*X""&N#`
M@#380)P5`($$_!P)/3"AN1R60W=A`J`:["$-<+`)"I'P2S-,-E]+2("EZ5("
M/VQ:7YX&=5WH]!_,8.`&J3:%!SPNRP-W8`420$/&JC"&,GR@#$*@`0/04(92
M!Z$&6$B#$;YU@FEBX.`^L`(9D#"$#HP`"@%@`QHT;>`<?D`&1G!!"5"@@1=P
M`00S$(`"S+>U+<SAR',``A#67<C_0[;[`'Z<-[VIX```Q($&;\B#'*1H18.9
M/`!&,`)H//"#`GS=4#-`0ZZ\8`0!V,':^Y*"!]ZA!@EH8`0?*``-8%FGI$[`
M!)/F<@)<*98_N(`,*[1`!Q3@ZD+)X0;&)1P:9K!IR^=<O`6P^H$QX(>@FZ($
M%"CZ$$<@`M!400)(6(`&XB"%F,U@!!,8S@HRYB()Z'T#%7A!&F2@@3*46*M+
M&<,'VAZ$#TCA6W\P53;`!'S@!TQ``D0V-7XW!W\G>$Y`/TUV`'60`1FE/LXR
M950V`C/P!AH``.6U`4O591>@"0_`!E[P`P+P>3X@`IX""V@@`^AG,!50!FE`
M+@QP`4B`_P=X<`,G,`HGH`$K%`$3H`!7,`2']@)M\"MML`#IAP,SQE]X<GS)
M]P@EP'R$4@//!PD;]!\O$0$_9WV30!B`IGT=@``T$`5Z\`/-]@(4X`9P`!H_
M@`#Q17(UD``'``0T(P/+]0%X,`-N<`,%4`#V]0MH8'-MMP0-``7`X`(G(`(H
M-P8+```A@#X*^`2!YX`/V&2%-($8!0-G,`49D`1RX`"\)0`BT('E-8JT=$;\
M4@+?TGF?UP,Q-'HO&(,P,8-O4`MJL`(3(`=OH&;T(EXV$(03T`!V`!^.T0%"
M8$)?0`8]P$)#8`?&!G,=``5P0'-6B'.?!GU<.'U`5PIBR$$3)O\'"Y`&`=`'
M0E!J/4`&<04:<``"!O!!,;$&9:0#0)`#5L`$!7`#?4```<!(QD$(!*!_Z7=@
M_7<#H:%+%3(&(Y`D&=5'(#`'(."`=5"1'_519Y!1@`0#>W`$HT@%,%``;Q`'
M&/`0)F`",]459W0!#"`CL'APLN@IO?""IX=#-3`"._`#/R`%EC$!LP8&P5@7
M<+``Q#@"QN82S,$%;<``/\"$/:$`"Q!A254HU7B-N1)F##EA6+B-6AA]:]"%
MU`>&I#"&=[(&GZ,]9A0!)#5U@@`'0O`!8\1E`3$!1)`'9-`&-"`CK3!T!(D9
M$?`!"*F7CS`-4/`$ZG0'*@`#,>`$3O#_!$_P@'7P;NQ6/Q2H>("$@50``'DP
MDB6)`X!%`B`8$(LS`2M0-"@8BRPX>B4`@VEY=0:0!,Q@&4$P`58@`OHA":NV
M``;PE1,P`@6@26803!C`!PQ`!DD0:65``5)08"`T1-;8`FSP%B6@?U>8A8^P
MA0;IA=6'"MA7=`>F5"&(`4QP`AKR!5(P`BAI11^T!%TXFQ?P`Z`P%XG@`7WY
MG8`YF"91`"^``7L``XD)`5QP`&<0&UT@F887`UT``Y9YF526`B9@`S)0`$<0
M!#@P`C:``$$5@E]!`0$@`9X'D[/H@C)P>NQY8%/41C"Q`7U("KFYFYEQ`2B`
M!SW@$O)(1BMP_P-,P%@X0`+1D`/,R1-5"9W229U=40$YAQ38^4':*9:C0)8?
MI$I6%*4(I@$_$!C3\`,1%E15%()=,0$*]`6@@1\?T@)H(`+[]YU_*05*!`G4
ML4'[Z0,]<%%<$YD'P`4!:J`(JC4+6F]4D`(`@`5DP`0`,&@C0`9I15A7%!`0
MP`?NIX*I"0NK>:8OH4JH9$5!L`$V(`&`,@DN0`.ZN4]#L`!M@`(CH&)*^D$)
M4`80L`1A$(TW(`$2-02GFAD4P`#_8C@S0$I*6@%(P)77&7U*:@$80`:I%B;W
ML"M.VD8;``!7<`6XQTD)@`?DR2OXI08%H&%!50%;JJ2SN0(M-19?T/\&^Z>D
M9O`!*#`*34`!#<`=.G``"<H!=QJ9=/IN71`#"KJG&)@",)`'!H@!@X8%,]!P
MZ*FM\AAS(""H8"<"39`4/`"##O"=9W8%1)A2%E`#>2`#!T(5G?H>;30$VB0!
M-D`"8Z2D-=`#+4<"99`#34`#'R"KISH$!?`#F(*KF[:KUOD'6QBLPVJK'N!G
M\[!Y7@!H_/6D#N!8&D8",R4'&I!R8LB4**`5@\489J">.90$9QB42R&N\=5&
MY7JNDR`&ZLH=$'!(1.")9W!1!2J9D;D^"TIO4Y8"#FH#.^!Y@X8`+"@"`L`2
MG*2DS4%#9K`$/:"PC_``#3L"R_1!.*!C>';_!1U@!A60!VW@4I+0J0B@8L*G
M`0R@$B,P!,'YI$NP`:`Z`D*`!OE50,'*5T*Q(:Y``#L`ET]JI+Z*LU#`6$\Z
MK'T`#`VV(8/P!;%$HSZ%;10@!&5P!#@```7@%K#0`FZP`A?PCP5@`VJ%>]H*
M1*.%`L8Q"5]@IMW%M>9*"E`P`ND$`854!%T06^AS!O%*/UV@D8KWMG![!3;0
M!I[W17:[&^A80#\$3$L@!Y:Q!"1`3(/+`^<97T_DF38`!0*`!3VP`2I*!NLU
MN310N6VDM'W``R*P`":PMT^D5&%P!5A`!R5$`R,0CW/T1`ZP2`3B`020JV-D
M`;"K<]<)!;**2L.J_P<,MA\9P@`<Y!)/-`1E0!^=!UP(4`#D*:8KH#Q5L`@2
MD!5:IJ5S-`380CB1\`4SL`+=]41=2PH[@`7IE`1=\#7Q9ID<T`4569&(IY$9
M56]PZP`-0`$20))?A`4B4`G&@`=;0;!SE&M+8`:RB"7X(<`C<,5?-`(Y(`8-
MBP4O,`),T`8>P:D1W+@6H+0,(`8;U``@*$=A@`-V4`!Z(`9@P``C+$<J^@.(
M@")5Z+H#=;,G(,/@27U'A!2=P@!28$<>(+1.U,-E<(9&X*$VH`%DP$-K4P47
M@`-+P`=]T`D,(`%2`%PF<,L>VP=2#`E4_`&7_$3W.0HT$+(&<`1[\#6))__&
M94RG6@`#3X(L#9H"<H``?B"_&/!%"S"+*NP'6)!/4[O!#&4&/H!_?PR#@HP#
M")`#M_$#4(`'3$"E=)`#G,H"F]O#(,``/2L">4"Q;F0&)(`%+*`.<%`&)#Q%
M%3`"/Z`)TLE\M_Q%JDP!0T!%`.`'#CT/G>`&>^``&D`)O8M*/LP"+](S?9`%
MQ^``!;#"*^!$E=92N#(Y!5!`#-4!<=`'6)N]U#Q%9M``7CL71J"N`/":S:`%
M[*MX''`&2""9[?8U&'#.&T`"-N`&8T`!`##(%\TE>K`#6F$`]>S4*^AGQ<//
M4X0#93`#L/```2`".Q``3M`!1S`=D>`"9GK2%K#_`0C@%DVC`0TP4ZD4!AL0
M>U5P"7\`!RC%4)0J9Q\=!?90`JT[TB_,C2@-=(/1*<=0`S@0%BTPTZHT!&:H
M"R44!4XS`68`!33@'@Z0R2]@1P;2UI5K!F9@`'@0`.`J`H'LU%`]"E&`!E*`
MH4>B#1#P1VU;9%W=9-Q@``X`M^C<``(`!RP@`&G]U"*`'[)@!#FP``K`N9&-
MSS'$L/P<`5:$UWJMPBGQ`WY@`#AP!-$1(P<R`PL\4"_@!FCP!V"0!9I$J55D
M`B-``R;T"B>``'`=I19@!AC@!E7P`+QP`CM@Q90ZVNJP08BM2@"P`ZEF#6Y`
M=I(==>"0?;?<JA[F`KP0_P4LX`2/9`8S(`(Y\!Y6M`%\P+3%PP!"L-LXX`/C
MR0YUD0XBL`(SA<4]@`*O@".P`#Z=IP`&(&D=D`3(4MTJ4*`@Y0RC"+?UA`59
MT`0!H`$&4.&!.QUO@2X$(,]%6,]A\&Q]%B,"[.'S709C0!UXTP=`\`+F]0([
MT"YLX"*"X@`,-><%X08G@`8,$`=7(.>:K`''+`MM\`+5#*7NY`<!4!\G,'9.
M5$4X\`+VY0'?PKL%T.2J9``4<-`H``5"D`33R^K=IP>(,[UAX*4H(`5TP`=`
ML`<@*-E`(`$@ZP-;2@1"L$TGT`=\,`7"[<-64"&+4"""`-HO\.(6/KHM\#/4
M(?\GSKT"N#<$$W"8YV.9,."N4Q";8;0!*5"\9T`!=M0&-C`!BBX#B+"PL@`'
MWXNT533G/M`&9P,A/)`%2+`!43KJ4)`#="`#<2!.K+H!;\4Q_'$!C-'O_5X!
M0Y`$=#!5FM3O!F"W:/`J1E"Y/V3Q_4YHW@`&=,`%'6#Q,>8#;-@N8'`!&#"U
M_>X3$S`!\&?S8>``'T`!-'`"0G`$!G_S%>``2&]0)V\"&B`!JPR7%R\'W6$`
MWF8&<M``>'#1OL`I7R`$/M`!N%Y%/I$$+]`')D@-IL$'#3D$&S`$DA8U4</-
MS(`!O,/`%9`"FI%FBH4!13_G0[`'%U"LKV`:)U6$8N__`Q(P*Y=``7O`WA>/
M]#I?\G..`?PJ%DI`!TD@^29O!AL@!`Q``WAP[9)]!43\"U_@!A-N\A;ON"]0
M!2#0N)N/`QOP`IW.`/JM^E,KW#?O`%!)!GK0![C&\S<_Y\1O529@!Q00=S>`
M!=F:^\(MW!5@`)NQ`Z]$%P+F`S@@_#?/^7R`!BW($2Z`&"^@W4@_!*1(9>A/
M!1A@`.S?`0X`?Q70]AZL9BSP`MF_^CA@`'007K``"'`H"%<.83@*+$TM?V@O
M%69ADI-A9I&1E7)E3'U_?R52'W)##@X;&Z5#0R0:#"=66$=R)`A22F(>:"P-
MHZ:GOPY#'4<@,QHDO:C!<A@7_WTE.0H&I*?!JM?!!@HC%"=Z;DC3I<K7JLLD
M=C8,7QXT!2,*)`9RP=DD'U@H<%XM#VPM+4JX68&AER]K!GQ(V>?%DX>')5C8
M4`!@R*\4*:ADM&9N0X6/&V:-\%,%V@HY'4I9D]/`3PD/GCQY>87EBAP`"%BX
M@,F@3$%JJ<I9`]!`0Y82?UKHD:)A1(,K)$R0F*K@PP(H#$K08+)B!)8"#!IZ
M<)$C#KRH)M*F):&@@0T*4F38^!!OZI4&9>*@Z(-&2H$R=>TV:*O@BH*V"#3T
M\1*1PH6G4TD8/GSXRMT1-F2(^>(%#`T-"#X,;D#:CAW,,AB@B?*@A0=^46A`
M64`7:O_DNPCBS-`S-J9#(U*P2+.X`:/Q7Z<^5D`URTX</7",2*"`X"G4NQ<*
MD'GI.VD`*P@0?%T,LT^!N;8E$ZY\U\X"&48\M8C21XH`&S86+`"QWP8>*`&4
MX`4!(LA`P0TT_.'"'P_!X=<"6&!11G@(E('%`GA0P`(<;O`11WX78OA?'W!\
MT0<*<6!A`P@7+&!#'OSIIY\`=)3H`F,Y%*"!?GGTZ&,>%]J@P5Y&>-"$!YS]
MT`8*3("X0!YXR"`"`2UXX04;;#S43P!C%(!'?B"`D-^3>/A!PX(Q/023!W#,
MD(<")M!300IFI(`##A7@"5(P`"A0!A0)OF;$#DS@H0$6>0C_"40.5334W1]L
MG.`'!5"(\-)#48C0Y)@\^M@BAA2XP0!,?W@Q5@EP_*!J`*P&0$,`)[16:A1&
MH*&'E6N^YD(5-/1*@PB]]M%'``S`4<(#41!PPJNM!E!%`%2R\84>KO[`P`^M
MPL'"AL)ZXY"5)9R@ZK@_O-HK"\6JQ@Y`#SSTQ1<///LK"R2B48)K7K#S4$PN
MA,MJK_^V2H"`CC*X;ZF>"5!&`R94Y`LPRP!PQ0A,S"`@IE'H02VS`?1Q`@'M
M/LI@OR7HX8)KKXW5Q[7DBMOK#\(:"X:I#I%:L\&F6NG:M_O2W)T'8HCAA1A*
M^/Q:4HP\NB]`*<MD<U(&/_3``SRK_VEPT$_OBS6[#]&\DP=LB-$$+J;FZ@'*
M:@)]8S^NX1*UJ8PXVK4')?P@18I/-0P``'(8`(`)E]D`X)4TLQ%%%`\I\9`8
M:-M\--([1YTV9VBR(\;/2C`H\N:<=^[YYZ"'+CKH\$H=-D`-Y:NF:S?J[,*-
M8(>LX-EK4IWSOK2CP<`,YX4V&FDC+%"`F0R%;.K)!K?=FI4U>P'[/SOC"G>6
MIK)1]M.C9Z_]]MQW+_(7*+?63\]EEVJES@_L=+(7:)`:10M4-H3OV0#5KS,!
M!/S`@A\WW&#%#7[(@2L(\#X70$]SIF('TER`K!:P07)8PEVNV-:T4O4,>][+
MH`8WF$'5+?_(@>=CA)JDIZ46"`UH"E1"/Q[`F*2D;"?LXD<#(56"DN&/@"YH
M@EA`!K=&1(%]7_"$X?C1PZY!CQ'O,A_];D>VWOB,@U",HA0Y)P8X@*`'/O`!
M$/I0-'Y4R0-T0`(6N2`%-`3Q(2S@`PC\$`4E)`L(?+C`"BX``B'PX7A_T`,*
M^`"'UWG`"'00@A#(@P8U7D`(0$"`#81`!Y/MB@)PC`*#X`#)"R!@CB``0EC`
MU@<^V/$$65*3$2Z`Q1X(851B.=@45\G*#7J@!Q@X0A(,8(`DY"!S54+#"HX0
M2UX:H`<R<`T;4&"`#L2A!$UX``%\,`0,D`"+&,``'Y!412P,P0#_*P`#K9#0
M`0RX@1T:.,(1?%!,#%S!`$=`04,(<(0A[($`KV$`-W^915JNX"$ND$(/.K`"
M4*KI`DF(ICAI20?GH:R5"$WHZ!XBA`H8@`)"(,A#%]&"+ZQ@`P9`0)@N8`H0
ML%"/>=+`"9I`@"HD(`P&P((<7W`$#1C!"T:``Q9P8`8'@*!87,!HS!;0`R2L
MP`%F.`("?'`$"J"!I$-`*0&^H)47F*$#"[CD"S#P@A(8P0C$Q`$7JH`X#PC!
M%"]8$0@`@`,AN"`*;$"30M?*5M_@TP48"`,&U$"#&1A*"B=H@0OX((<*O,`*
M5H`"!3[P`0H$*``4R-,"1,``-;SAI`:P_X*4\`,@NK'@HD!UP`5$L()NLL!5
M**!`'/(P!#/X``]"H,`,C.`&&B15#@'(V`T:\%0H0.$&YP%0"?I``0/@(`,T
MT(/N?.L#"@06"A=X08W8X(^V.I>M$&%!#PXQ!&:L(`=N\`8-/E"!(93A!F-@
M@8$HD`,]E$!3><H)'$1@!0.$P0%7R$`[5T"#*CQ`#YQU0$%J&E4Y'($%UK(;
M%/(`5!(P@0^?Y4$6<O#:,:"A#U90@!DVT(,>R&(%]'(!#>+@VQZ,H0I5`,%R
M_KJ#']"!#Q0001^8AL'GNCB*=),"`C!@$9I60)JH\H,/S""'//CA!"5@`+VR
MT@01X"&];8`##?^L((<P#*$!4ZW`"N#@#R/T`0$.\,$52HL!+OB7!JJ!0Q]V
M@(?2^L`*HM*#&"20A0;3IP!7J.D+7N`#![S`""70,(=QT`,4U+<'-?V`%1C`
M`R/TRKQI>[&BIYB+'##!#@WP@3S,@(,D//@&1S##$+!``Q:Z``UG;:,(;(#D
M5!7`O7)0$2DUL*!<](&C?NJ!`W#0@0[X@`;WZA<+XF#F&^@A"F!HP0DH\-HT
M5,$\@!Y"HGBZ@&=X8=<=]C,-`.W7&Q``#6S@ZL$\(,E%>YN#+NC#"IB0AS*4
MP0Y-EH.V"O""#>"@JE_K0QQR`)`9V,#="!#!"20@`%0#U@\B8`%82D#_`!J`
M0`XCP$,9?%"!0V"`!B";#^]*V^=CZ54--^A`&#J0AOQ1(-EQ8$(!*(""V+H`
MVGP6P0]V@(`-R!4%+F#'`T!0T-D]\-LX[YX'],"""C@@`Q>X@`]0\0$_WR`6
M.*`P(E]070V4Y`<KB,0+VE"%'PC!Y1M00(4-L($.C*H$8W@!#HX`A3@0PN6P
MM7@4&'!1E.;`".UJ@1H*X'('J*$*$@"">W$0AQV(X`T!H-ZKDXH!*3!``AKP
MP9T,0/,+<!T$_3)5MW-.^86>2-83\%L'`,`%&X@@`$9>00]&0<OJDM&\/Q`[
M#DA`AJI?E-+"&,)R,N`&/1#@!AC`@0'XX&B?_VS@X6@`2!18H(`-F.&A/-A9
M%?)@_"'<(`H_T$`'S%`!&QCA<(=K!-N!:H`"].$'!4#`"PS@`&:DI`<"9`?R
M*L]^T'G@1'A`@"4U"@(-`(H->I@!!:)Z2?F#(,70T08:0%@@0'59(`0?\`)<
ML`""5'\%X"Q5X`<:4']T\`-I$'\K4`Q%X@$%-Q<?@``R<"E_P`!0D(`7<`-6
M10$K0%A0\`.)Y@7RM@)<@`!^$!WN8`/A84F'1%Y],!8-H5;M%X1*HRV4(E@%
M<`-0(`,L4`)B<P)=4@`%(%BVA2!1X`(_4'9QP`<2H`<,D`5XD"A6@`)(B(2!
M%Q$H<%LBD"I20`%1V+T'1R(&:X<B<1`'$J!#)H0&**`C<?`&AJ,I<S@#)Y`U
M#"`%@E0`9_(%!,*&%,"&_V8IM+,30AB)(N,"VD(OPF(R/[-;PB(L#'`KGD")
MV[(/GA`1.4`OED@B"\(8#+`RE0,=GL@O8H8ND!@3NT4O2$$W?6"+(L,8N<@`
M0!ANPK(MSR")Q.@YNN)'+:8F+F!>LX@SY<,@YY,R5B,YVY9H:?(:SWB-SS@W
9+0:-V>B-*?-$Q3B..C>-Y*A!JA0Z@0``.S\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
